Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori.
Duggan
A
A
Williamson
R
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000382:microbiology*; D005069:Evaluation Studies as Topic; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents